Herbal Nanocarriers for Enhanced Drug Delivery: A New Frontier in Pharmacognosy

Robert Colwell^*
*Correspondence: Robert Colwell, Department of Biological Sciences, University of Michigan, Ann Arbor, USA, Email:

Introduction

Herbal medicines have been a cornerstone of traditional healing systems for centuries, offering a wide variety of bioactive compounds with potential therapeutic benefits. However, their clinical application is often limited by challenges such as poor solubility, low bioavailability, and rapid metabolism. The integration of nanotechnology into herbal medicine has opened a new frontier in pharmacognosy, leading to the development of herbal nanocarriers. These nanocarriers, including nanoparticles, liposomes, dendrimers, and micelles, enhance the solubility, stability, and bioavailability of herbal bioactive compounds. This article reviews the current advancements in the use of herbal nanocarriers for enhanced drug delivery. We explore their types, mechanisms of action, advantages, and challenges, and discuss how these systems are revolutionizing the delivery of herbal-based therapeutics.

The therapeutic use of herbal medicine has gained widespread recognition due to its rich array of bioactive compounds that exhibit various pharmacological properties, including anti-inflammatory, antimicrobial, anticancer, and antioxidant activities. However, many herbal drugs face significant limitations when administered orally or topically, such as poor water solubility, low systemic bioavailability, rapid metabolism, and limited tissue targeting. To overcome these barriers, the use of nanotechnology has emerged as a promising strategy to enhance the therapeutic potential of herbal drugs.

Nanocarriers are colloidal systems with nanoscale dimensions, typically ranging from 1 to 1000 nanometers, designed to deliver drugs in a controlled, targeted, and efficient manner. When combined with herbal compounds, these nanocarriers not only improve the pharmacokinetic properties of the active ingredients but also allow for precise targeting to specific tissues, reducing side effects and improving therapeutic outcomes. This review aims to examine the use of herbal nanocarriers in drug delivery, focusing on their design, advantages, applications, and challenges in modern pharmacognosy.

Nanocarriers are versatile platforms that can be tailored to optimize the delivery of herbal compounds. Various types of herbal nanocarriers have been developed, each with distinct properties and advantages. Some of the most commonly used herbal nanocarriers include nanoparticles, liposomes, dendrimers, and micelles. Nanoparticles are solid colloidal particles with a size range typically between 1 and 100 nm. They can be composed of a variety of materials, such as lipids, polymers, or inorganic substances, and can encapsulate herbal bioactive compounds within their structure. These particles improve drug stability and bioavailability while allowing for sustained release. Herbal nanoparticles are particularly effective in enhancing the oral and systemic bioavailability of poorly water-soluble compounds.

Description

Curcumin, a bioactive polyphenolic compound from Curcuma longa, has poor solubility and bioavailability when taken orally. Curcumin-loaded nanoparticles, such as poly(lactic-co-glycolic acid) nanoparticles, have shown increased stability, enhanced absorption, and better therapeutic effects in vivo compared to free curcumin. Liposomes are spherical vesicles made of lipid bilayers that can encapsulate both hydrophilic and hydrophobic herbal compounds. Liposomes enhance the bioavailability of herbal drugs by facilitating their transport across biological membranes. The lipidic structure also provides protection to the encapsulated compounds from enzymatic degradation, while their surface properties can be modified for targeted drug delivery.

The use of liposomes for delivering plant polyphenols, such as quercetin from Allium cepa, has been explored to improve their stability and bioavailability. Liposomal formulations of quercetin have shown enhanced antioxidant and anti-inflammatory effects compared to free quercetin [1- 3]. Dendrimers are highly branched, tree-like polymers that offer a unique structure with a high surface area for the encapsulation of herbal drugs. Their uniform size, well-defined shape, and functional surface groups allow for controlled drug release, targeted delivery, and reduced toxicity. Dendrimers can be engineered to carry a variety of herbal bioactive compounds, offering significant therapeutic advantages. Dendrimer-encapsulated resveratrol, a polyphenol from Vitis vinifera, has been shown to enhance the compound’s solubility, bioavailability, and antioxidant activity, making it a promising candidate for cancer and cardiovascular diseases.

Micelles are nanosized aggregates of amphiphilic molecules, with a hydrophilic exterior and a hydrophobic core, capable of solubilizing hydrophobic herbal compounds. Micellar formulations are particularly useful in improving the solubility and stability of poorly water-soluble herbal drugs, facilitating their delivery to the target site with minimal systemic exposure. The use of micellar nanocarriers for the delivery of β-caryophyllene, a sesquiterpene from Caryophyllus aromaticus (clove), has been explored to enhance its bioavailability and anti-inflammatory effects.

Many herbal bioactive compounds, such as curcumin, resveratrol, and epigallocatechin gallate, suffer from poor solubility in water. Nanocarriers can encapsulate these compounds in hydrophilic cores or lipid layers, significantly improving their solubility and stability. This increased solubility enhances absorption in the gastrointestinal tract and increases systemic bioavailability. Nanocarriers can be designed to release herbal compounds in a controlled and sustained manner, ensuring that the drug remains active in the body for extended periods of time. This approach minimizes fluctuations in drug concentration and improves therapeutic outcomes by maintaining the drug at optimal levels in the bloodstream.

Surface modifications of nanocarriers with ligands such as antibodies, peptides, or carbohydrates enable them to specifically target diseased tissues or cells. This targeted approach reduces the side effects associated with systemic drug administration and ensures that the bioactive herbal compound is delivered precisely where it is needed, improving the overall efficacy of the treatment. Nanocarriers are small enough to interact with cellular membranes, allowing for enhanced uptake by target cells. By modifying the size, shape, and surface charge of the nanocarriers, they can be designed to cross biological barriers such as the blood-brain barrier, which would otherwise limit the effectiveness of certain herbal compounds [4,5].

The use of herbal nanocarriers has shown great promise in the delivery of a wide range of herbal compounds, including polyphenols, alkaloids, terpenoids, and flavonoids, to treat various conditions. Cancer treatment often involves the use of chemotherapeutic agents, which can have severe side effects. Herbal nanocarriers offer a promising solution by improving the bioavailability and specificity of natural anticancer compounds, reducing toxicity, and enhancing their therapeutic effects. For example, curcuminloaded nanoparticles have been explored in the treatment of various cancers, including breast, lung, and colon cancers. Herbal compounds such as ginkgo biloba, bacopa monnieri, and resveratrol have shown promise in treating neurological conditions such as Alzheimer's disease, Parkinson's disease, and cognitive decline. Nanocarriers can improve the delivery of these compounds to the brain, overcoming the challenges of the blood-brain barrier and enhancing their therapeutic efficacy.

Chronic inflammation and oxidative stress are central to the pathogenesis of many diseases, including cardiovascular disease, diabetes, and arthritis. Herbal nanocarriers can enhance the delivery of anti-inflammatory and antioxidant compounds, such as flavonoids and terpenes, to reduce oxidative damage and inflammation. For instance, quercetin-loaded nanoparticles have demonstrated significant anti-inflammatory and antioxidant effects in in vivo models.

Nanocarriers can be used to improve the delivery of herbal antimicrobial agents, offering a potential solution to combat infections, particularly those caused by antibiotic-resistant pathogens. Plant-derived compounds like berberine and garlic-derived allicin have been encapsulated in nanocarriers for enhanced antimicrobial efficacy. While the development of herbal nanocarriers has shown great promise, several challenges remain:

The long-term safety and toxicity of herbal nanocarriers must be thoroughly assessed before they can be used in clinical practice. The materials used to prepare the nanocarriers, as well as the release profiles of encapsulated compounds, must be evaluated for potential toxicity. The variability in the composition of herbal products can affect the reproducibility and consistency of nanocarrier formulations. Standardization of herbal extracts and nanocarrier systems is necessary to ensure consistent therapeutic outcomes. While nanocarriers have demonstrated promising results in laboratory settings, scaling up production for clinical use can be challenging and costly. Advances in manufacturing technologies will be essential to make herbal nanocarriers more accessible.

Conclusion

While nanocarriers have demonstrated promising results in laboratory settings, scaling up production for clinical use can be challenging and costly. Advances in manufacturing technologies will be essential to make herbal nanocarriers more accessible. While nanocarriers have demonstrated promising results in laboratory settings, scaling up production for clinical use can be challenging and costly. Advances in manufacturing technologies will be essential to make herbal nanocarriers more accessible.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Pirintsos, S. A., M. Bariotakis, M. Kampa and G. Sourvinos, et al. "The therapeutic potential of the essential oil of Thymbra capitata (L.) Cav. Origanum dictamnus L.and Salvia fruticosa Mill. and a case of plant-based pharmaceutical development." Front Pharmacol 11 (2020): 522213.

Google Scholar, Crossref, Indexed at

2. Chan, Kelvin, Debbie Shaw, Monique SJ Simmonds and Christine J. Leon, et al. "Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica." J Ethnopharmacol 140 (2012): 469-475.

Google Scholar, Crossref, Indexed at

3. Li, Jesse W-H and John C. Vederas. "Drug discovery and natural products: End of an era or an endless frontier?." Sci 325 (2009): 161-165.

Google Scholar, Crossref, Indexed at

4. Sarkhail, Parisa, Latifeh Navidpour, Mahban Rahimifard and Negar Mohammad Hosseini, et al. "Bioassay-guided fractionation and identification of wound healing active compound from Pistacia vera L. hull extract." J Ethnopharmacol 248 (2020): 112335.

Google Scholar, Crossref, Indexed at

5. Coats, Paul, Simon Kennedy, Susan Pyne and Cherry L. Wainwright, et al. "Inhibition of non-Ras protein farnesylation reduces in-stent restenosis." Atherosclerosis 197 (2008): 515-523.

Google Scholar, Crossref, Indexed at